KIHT ties up with BioCubaFarma & BIRAC to usher in transfer of technologies & commercialization of innovative healthcare productsRead Now
A Letter of Intent (LoI) has been signed between BioCubaFarma, Biotechnology Industry Research Assistance Council (BIRAC) and Kalam Institute of Health Technology (KIHT) with focus on exchange of technologies, products, innovations, transfer of technologies and commercialization of innovative healthcare products of interest to both the countries.
BioCubaFarma is the Cuban organization of biotechnology and pharmaceutical industries which manages the country’s efforts towards manufacturing medicines, diagnostics and medical equipment. It also serves as a gateway for potential partners and investors interested in accessing the extensive biopharma resources Cuba has to offer.
KIHT is the premier institute of the country for promoting back end support to the growing medical technology and plays an active role in supporting activities related to research on critical components of health technologies, commercial exploitation of newer technologies, apart from being a front runner in providing regulatory and non-regulatory support for stakeholders in health technologies.
Industry leaders applauded the active role played by KIHT in promoting the increasingly growing strength of India in the medical technology field.
With this collaboration, KIHT has made its mark again in international collaboration related to healthcare technologies by being part of the Indian delegation which visited to Cuba as part of the visit of the President of India during June 21 to 23, 2018.
Y. Madhuri, expert in Biomedical Technology represented KIHT in the delegation. The delegation comprising of experts from health technology sought to explore collaboration opportunities between the two countries in the area of biotechnology. The delegation was led by BIRAC along with KIHT.
Delegation also comprised of industry experts who demonstrated India’s strength in medical technology from developing efficacious vaccines, to indigenously manufactured kidney dialysis machine with remote monitoring.
The visit of the technical experts enabled India to take note of the tremendous opportunities for collaboration in the area of biotechnology between the two countries.
KIHT recently tied up with Joanna Briggs Institute (JBI), University of Adelaide as the affiliated group. With this, KIHT would focus on medical devices and diagnostic and associate with other JBI centres in this domain of research.
All the studies done in this space would be submitted to JBI and KIHT would support and lead JBI in medical devices and diagnostic space globally.
Andhra Pradesh MedTech Zone Ltd (AMTZ), India’s first government funded medical devices manufacturing park would now be also hosting JBI along with cluster of 250 manufacturing units. The park includes common scientific facilities like electro-magnetic interference testing, biomaterials testing, gamma irradiation, rapid prototyping centre, etc., Indian biomedical skill consortium, World Health Organization (WHO) pre-qualification cell, directorate of radiation and medical devices promotion council.
These institutes would contribute in developing standard and quality in Indian medical technology industry and services and bring Indian market at par with global market.
The Joanna Briggs Collaboration (JBC) is a key body that contributes to the global success of the Joanna Briggs Institute, with respect to scholarly outputs and geographic footprint. The JBC has grown exponentially over the course of the 20-year history of the Institute and now incorporates more than 80 entities internationally across five regions of the world